Risio M, Coverlizza S, Ferrari A, Candelaresi G L, Rossini F P
Department of Oncology, Ospedale S. Giovanni Battista, Turin, Italy.
Gastroenterology. 1988 Apr;94(4):899-906. doi: 10.1016/0016-5085(88)90545-8.
A monoclonal antibody to bromodeoxyuridine was used in tissue specimens previously incubated with bromodeoxyuridine to show S-phase cells by immunohistochemical technique. Biopsy specimens of normal mucosa (n = 10), hyperplastic polyps (n = 10), adenomas with low-grade dysplasia (n = 20), adenomas with high-grade dysplasia (n = 10), and invasive adenocarcinomas (n = 10) of the large bowel were studied. Labeling index and cell proliferative patterns were analyzed. No statistically significant difference was found in labeling index between normal mucosa and hyperplastic polyps or between adenomas with high-grade dysplasia and adenocarcinomas. The labeling index was significantly lower in normal mucosa and in hyperplastic polyps than in adenomas and adenocarcinomas (p less than 0.001). The difference in labeling index between adenomas with high-grade dysplasia and low-grade dysplasia was also statistically significant (0.01 less than p less than 0.05). In normal mucosa and in hyperplastic polyps the proliferative zone was confined to the lower two-thirds of the crypt; no kinetic activity was found in the upper portions of the crypt or in surface epithelium. In adenomas the labeled cells were either present in the upper third or scattered along the whole axis of the crypt and in the surface epithelium. Labeling patterns in invasive carcinomas were similar to those observed in adenomas with high-grade dysplasia. The difference in proliferative patterns between hyperplastic polyps and adenomas supports a different significance of the two polypoid lesions in the histogenesis of large bowel cancer; our results confirm the subsequent steps of the adenoma-carcinoma sequence. Immunohistochemical labeling patterns observed with monoclonal antibody to bromodeoxyuridine in polypoid and cancer lesions of the large bowel are similar to those described by autoradiographic studies.
将一种针对溴脱氧尿苷的单克隆抗体用于先前用溴脱氧尿苷孵育过的组织标本,通过免疫组织化学技术显示S期细胞。研究了大肠正常黏膜活检标本(n = 10)、增生性息肉(n = 10)、低级别异型增生腺瘤(n = 20)、高级别异型增生腺瘤(n = 10)和浸润性腺癌(n = 10)。分析了标记指数和细胞增殖模式。正常黏膜与增生性息肉之间或高级别异型增生腺瘤与腺癌之间的标记指数未发现统计学上的显著差异。正常黏膜和增生性息肉中的标记指数显著低于腺瘤和腺癌(p < 0.001)。高级别异型增生腺瘤与低级别异型增生腺瘤之间的标记指数差异也具有统计学意义(0.01 < p < 0.05)。在正常黏膜和增生性息肉中,增殖区局限于隐窝的下三分之二;在隐窝上部或表面上皮中未发现动力学活性。在腺瘤中,标记细胞要么存在于上三分之一,要么沿隐窝的整个轴以及表面上皮分散分布。浸润性癌中的标记模式与高级别异型增生腺瘤中观察到的相似。增生性息肉与腺瘤之间增殖模式的差异支持了这两种息肉样病变在大肠癌组织发生中的不同意义;我们的结果证实了腺瘤 - 癌序列的后续步骤。在大肠息肉样和癌性病变中用针对溴脱氧尿苷的单克隆抗体观察到的免疫组织化学标记模式与放射自显影研究中描述的相似。